U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be ...

The prospects of higher pay, regular hours, comprehensive benefits, and career growth has workers filling biotech training ...

Roughly 30% of American patients have skipped doses of their medicines, cut pills in half, or declined to fill a prescription due to cost concerns in the past year.

Details of a new drug that aims to treat the underlying causes of obesity are being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...